Tango Therapeutics, Inc. (TNGX) Stock
NASDAQ · TNGX
Key stats
- Market cap
- $3.63B
- Price / Earnings ratio
- -28.4x
- EPS (TTM)
- -$0.85
- Volume
- Loading
- 52-week high
- $34.39
- 52-week low
- $7.37
Source: third-party data provider
Compare with TNGX
Latest news
About Tango Therapeutics, Inc.
No description available.
SectorHealthcare
IndustryBiotechnology
Employees137
CEODr. Malte Peters M.D.
IPO DateSep 3, 2020
HeadquartersBoston, MA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Malte Peters M.D. | President, CEO & Director | 1962 |
| Mr. Matthew Gall M.B.A. | Chief Financial Officer | 1977 |
| Dr. Barbara L. Weber M.D. | Executive Officer | 1957 |
| Dr. Adam S. Crystal M.D., Ph.D. | President of Research & Development | 1977 |
| Prof. Alan Ashworth FRS, Ph.D. | Founder & Member of Scientific Advisory Board | 1961 |
| Dr. William G. Kaelin Jr., M.D. | Founder & Member of Scientific Advisory Board | 1958 |
| Dr. Antoni Ribas M.D., Ph.D. | Founder & Member of Scientific Advisory Board | 1967 |
| Mr. Jannik N. Andersen Ph.D. | Chief Scientific Officer | — |
| Ms. Elizabeth Pingpank Hickin | VP of IR & Corporate Communications | — |
| Ms. Julie Fogarty | Senior VP, General Counsel & Corporate Secretary | — |
Fundamentals
Valuation
Price-to-sales ratio56.41
Price-to-book value3.43
Profitability
Return on Equity-26.00%
Return on Assets-23.00%
Return on Sales-230.00%
EBITDA$-117.97M
Trading
Average volume4,479,296
Source: third-party data provider
Analyst views
Seasonality
Corporate actions
Upcoming
Past
Compare stocks
Market cap
$3.63B
-
-
-
Price / Earnings ratio
-28.40
-
-
-
Price / Sales ratio
56.41
-
-
-
Dividend yield
0.00%
-
-
-
Average volume
4,479,296
-
-
-
Earnings per share
$-0.85
-
-
-



